PT Hetzer Medical Indonesia Tbk (IDX:MEDS)
Indonesia · Delayed Price · Currency is IDR 74.00
-1.00 (-1.33%)
Sep 2, 2026, 2:17 PM WIB
IDX:MEDS Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 117,188 | 110,938 | 78,125 | 106,250 | 209,375 | - | |
Market Cap Growth | 38.89% | 42.00% | -26.47% | -49.25% | - | - |
Enterprise Value | 123,140 | 117,484 | 83,546 | 114,611 | 211,480 | - |
Last Close Price | 75.00 | 71.00 | 50.00 | 68.00 | 134.00 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 883.21 | - |
PS Ratio | 7.81 | 16.74 | 12.22 | 4.68 | 5.55 | - |
PB Ratio | 2.41 | 2.30 | 1.38 | 1.63 | 3.04 | - |
P/TBV Ratio | 2.41 | 2.30 | 1.38 | 1.63 | 3.04 | - |
P/FCF Ratio | - | - | 39.98 | - | - | - |
P/OCF Ratio | - | - | 35.03 | 33.71 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.20 | 17.72 | 13.07 | 5.04 | 5.60 | - |
EV/EBITDA Ratio | - | - | - | 116.33 | 29.15 | - |
EV/EBIT Ratio | - | - | - | - | 46.45 | - |
EV/FCF Ratio | - | - | 42.75 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.13 | 0.17 | 0.09 | 0.12 | 0.15 | 0.35 |
Debt / EBITDA Ratio | 25.11 | - | - | 4.92 | 1.33 | 0.32 |
Debt / FCF Ratio | - | - | 2.66 | - | - | - |
Net Debt / Equity Ratio | 0.12 | 0.15 | 0.09 | 0.11 | 0.07 | 0.31 |
Net Debt / EBITDA Ratio | -46.20 | -1.67 | -1.11 | 7.44 | 0.64 | 0.28 |
Net Debt / FCF Ratio | -1.60 | -2.64 | 2.54 | -2.50 | -0.15 | -0.73 |
Asset Turnover | 0.23 | 0.10 | 0.09 | 0.29 | 0.58 | 1.87 |
Inventory Turnover | 0.81 | 0.53 | 0.47 | 0.72 | 1.14 | 3.90 |
Quick Ratio | 0.31 | 0.17 | 0.87 | 1.53 | 2.32 | 0.59 |
Current Ratio | 1.18 | 1.17 | 2.88 | 3.72 | 9.03 | 1.91 |
Return on Equity (ROE) | -8.20% | -15.91% | -14.02% | -5.33% | 0.47% | 117.08% |
Return on Assets (ROA) | -3.89% | -8.13% | -7.61% | -2.06% | 4.35% | 52.65% |
Return on Invested Capital (ROIC) | -7.32% | -14.13% | -12.94% | -3.57% | 3.13% | 121.59% |
Return on Capital Employed (ROCE) | -8.10% | -16.70% | -14.60% | -3.70% | 5.90% | 80.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -3.55% | -7.52% | -10.92% | -3.36% | 0.11% | - |
FCF Yield | -3.18% | -2.46% | 2.50% | -2.76% | -14.80% | - |
Payout Ratio | - | - | - | - | - | 27.04% |
Buyback Yield / Dilution | - | - | - | -13.78% | -9.86% | - |